Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 509.00
Bid: 506.00
Ask: 512.00
Change: 11.00 (2.20%)
Spread: 6.00 (1.186%)
Open: 503.00
High: 512.00
Low: 508.00
Prev. Close: 501.00
OCI Live PriceLast checked at -
Oakley Capital Investments is an Investment Trust

To achieve capital appreciation through investments in a diversified portfolio of private mid-market businesses primarily in Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of intergenia Holding GmbH

17 Dec 2014 10:30

RNS Number : 0181A
Oakley Capital Investments Limited
17 December 2014
 



17 December 2014

 

 

Oakley Capital Investments Limited

 

Disposal of intergenia Holding GmbH generates 2.5x money multiple and 36% IRR for Oakley Funds

 

 

Oakley Capital Investments Limited (AIM:OCL, OCIL, the "Company"), the AIM company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. ("Fund I") and its successor fund, Oakley Capital Private Equity II ("Fund II", together the "Funds"), announces Fund II and its co-owner Bellaxa AG's agreement to dispose of intergenia Holding GmbH and its subsidiaries ("intergenia") to HEG Co. GmbH ("Host Europe"), for an enterprise value of €210 million. The consideration will be satisfied in cash.

 

The transaction is expected to generate a 2.5x gross money multiple for the Funds, with an IRR of 36%. Fund II's indirect share of the proceeds of the disposal will be distributed by the intermediate holding structure to Fund II and subsequently to its limited partners, including OCIL. OCIL will receive €21 million, which will be applied in pursuance of the Company's investment policy.  

 

intergenia is headquartered in Cologne and is a leading supplier of Internet hosting solutions (in particular of managed and dedicated server hosting). intergenia provides a wide range of shared, dedicated and fully-managed solutions (also in the form of cloud hosting) through its brands PlusServer, serverloft, Server4You and Unmetered.com. In addition, intergenia operates Datadock, Europe's greenest data centre. The company also runs WorldHostingDays, the largest series of hosting trade shows worldwide. intergenia generated earnings before interest, tax depreciation and amortisation ("EBITDA") of €13.8 million in the financial year ending 31 December 2013. intergenia's current run-rate EBITDA is above €20 million following recent acquisitions.

 

This disposal follows Fund I's agreed divestment of its 13.6% stake in Daisy Group plc ("Daisy") for a gross consideration of £67 million following Daisy's acquisition by a consortium consisting of Matthew Riley (Daisy CEO), Toscafund Asset Management LLP and Penta Capital LLP.

 

Fund I is now fully invested and following the Daisy disposal will have generated a gross money multiple of 2.2x and an IRR of 38% on a realised and unrealised basis since its inception in 2007, and will have returned 115% of its drawn commitments to Investors.

 

Completion of the intergenia transaction is conditional on approval from the German and Austrian merger control authorities.

 

Peter Dubens, Director, commented:

 

"intergenia has successfully executed its buy and build strategy during 2014 under the excellent management of its founders, further strengthening its business as one of Germany's strongest suppliers of Internet hosting solutions. The complementary combination of intergenia and Host Europe Group will create one of the most successful and comprehensive hosting businesses in Europe and will create a strong platform for continued organic growth. On completion this will be the first disposal for Fund II and represents a good return for investors over a short period of time. This transaction is a great example of Oakley's expertise in the TMT sector and its ability to identify and back top performing entrepreneurs to rapidly grow their companies."

 

Further information will follow at the time of Completion.

 

- ends -

 

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens (Director)

FTI Consulting

+44 20 3727 1000

Edward Bridges / Emily Desmier

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Tom Fyson

 

 

About Oakley Capital Investments Limited ("OCIL")

Oakley Capital Investments Limited is a Bermudan based company listed on AIM. OCIL seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P., Oakley Capital Private Equity II and, over time, through co-investment opportunities.

 

About Oakley Capital Private Equity L.P. ("Fund I") and Oakley Capital Private Equity II ("Fund II")

Oakley Capital Private Equity L.P. and its successor fund, Oakley Capital Private Equity II, are both unlisted mid-market private equity funds with the aim of providing investors with significant long term capital appreciation. The investment strategy of both funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. Both funds seek to invest in companies with scale in their industry subsectors, thereby creating a sustainable earnings stream which should command a premium on exit.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISLLFIIFDLDLIS
Date   Source Headline
28th Jun 20247:00 amRNSOakley agrees sale of its investment in idealista
11th Jun 20247:00 amRNSOakley to invest in cybersecurity firm I-TRACING
7th Jun 20247:00 amRNSDirector Dealing
3rd Jun 20243:43 pmRNSResult of AGM
28th May 20247:00 amRNSOakley Capital invests in ProductLife Group
14th May 20247:00 amRNSOakley Capital invests in vitroconnect
8th May 20247:00 amRNSNotice of Annual General Meeting
24th Apr 20247:00 amRNSTrading Update for the 3 months ended 31 March 24
2nd Apr 20244:17 pmRNSUpdate from QuotedData
27th Mar 20247:00 amRNSDirector Dealing
27th Mar 20247:00 amRNSDirector Dealing
26th Mar 20245:46 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSOakley Capital invests in Horizons Optical
15th Mar 20244:00 pmRNSQuotedData's Weekly News & Interview
14th Mar 20245:32 pmRNSDividend Declaration
14th Mar 20247:00 amRNSAnnual Results 2023
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.